Publications by authors named "Edward C Stack"

39Publications

MYC Overexpression at the Protein and mRNA Level and Cancer Outcomes among Men Treated with Radical Prostatectomy for Prostate Cancer.

Cancer Epidemiol Biomarkers Prev 2018 02 15;27(2):201-207. Epub 2017 Nov 15.

Department of Oncologic Pathology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-17-0637DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831163PMC
February 2018

Multiplexed tissue biomarker imaging.

J Immunother Cancer 2016 16;4. Epub 2016 Feb 16.

Department of Immuno-Oncology, City of Hope, Duarte, CA USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-016-0115-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754920PMC
February 2016

Expression Levels of DNA Damage Repair Proteins Are Associated With Overall Survival in Platinum-Treated Advanced Urothelial Carcinoma.

Clin Genitourin Cancer 2016 08 24;14(4):352-9. Epub 2015 Dec 24.

Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2015.12.029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508512PMC
August 2016

Measuring PI3K Activation: Clinicopathologic, Immunohistochemical, and RNA Expression Analysis in Prostate Cancer.

Mol Cancer Res 2015 Oct 29;13(10):1431-40. Epub 2015 Jun 29.

Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. Broad Institute of Harvard and MIT, Cambridge, Massachusetts. Division of Cancer Studies, King's College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-14-0569DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618038PMC
October 2015

Androgen receptor CAG repeat polymorphism and risk of TMPRSS2:ERG-positive prostate cancer.

Cancer Epidemiol Biomarkers Prev 2014 Oct 12;23(10):2027-31. Epub 2014 Jun 12.

Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-14-0020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184923PMC
October 2014

Neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin with pegfilgrastim support in muscle-invasive urothelial cancer: pathologic, radiologic, and biomarker correlates.

J Clin Oncol 2014 Jun 12;32(18):1889-94. Epub 2014 May 12.

Toni K. Choueiri, Susanna Jacobus, Joaquim Bellmunt, Angela Qu, Edward C. Stack, Sabina Signoretti, Meghara Walsh, Graeme Steele, Michelle Hirsch, Christopher J. Sweeney, Mary-Ellen Taplin, Adam S. Kibel, Katherine M. Krajewski, Philip W. Kantoff, Robert W. Ross, and Jonathan E. Rosenberg, Dana-Farber Cancer Institute and Brigham and Women's Hospital; Christopher Tretter, Lahey Clinic, Burlington; Glenn J. Bubley, Beth Israel Deaconess Medical Center, Boston, MA; Leonard J. Appleman, University of Pittsburgh, Pittsburgh, PA; and Jonathan E. Rosenberg, Memorial Sloan-Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.52.4785DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057274PMC
June 2014

Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib.

Cancer Discov 2014 May 13;4(5):546-53. Epub 2014 Mar 13.

Departments of 1Medical Oncology and 2Biostatistics and Computational Biology, 3Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute; Departments of 4Medicine and 5Pathology, Brigham and Women's Hospital, Harvard Medical School; 6Division of Hematology/Oncology, Massachusetts General Hospital, Boston; 7Broad Institute of Harvard and MIT; 8Department of Biology, Whitehead Institute for Biomedical Research; 9Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts; and 10Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-13-0353DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122326PMC
May 2014

Integrative analysis of 1q23.3 copy-number gain in metastatic urothelial carcinoma.

Clin Cancer Res 2014 Apr 31;20(7):1873-83. Epub 2014 Jan 31.

Authors' Affiliations: Departments of Biostatistics and Computational Biology, and Medical Oncology; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute; Department of Biostatistics, Harvard School of Public Health; Department of Pathology; Translational Medicine Division, Brigham and Women's Hospital, Boston; Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Sidney Kimmel Cancer Center; Department of Pathology, Johns Hopkins University, Baltimore, Maryland; Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York; and Hospital del Mar Research Institute-IMIM, Barcelona; and Hospital Parc Tauli, Sabadell, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-0759DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975677PMC
April 2014

Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG.

J Natl Cancer Inst 2013 Dec 30;105(24):1881-90. Epub 2013 Nov 30.

Affiliations of authors: Department of Epidemiology (AP, AM, MF, REG, KLP, JRR, EJN, MJS, ELG, LAM) and Department of Nutrition (MJS, ELG), Harvard School of Public Health, Boston, MA; Channing Division of Network Medicine (AP, KLP, JRR, MJS, ELG, LAM) and Division of Preventive Medicine (HDS) , Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Pathology, Brigham and Women's Hospital, Boston, MA (RTL, ECS, ML); Center for Molecular Oncologic Pathology (RTL, RF, ECS, MF, SF, NEM, ML), Department of Radiation Oncology (NEM), and Lank Center for Genitourinary Oncology (PWK), Dana-Farber Cancer Institute, Boston, MA; University of Dublin, Trinity College, Dublin, Ireland (RF, SF); Pathology Unit, Addarii Institute, S. Orsola-Malpighi Hospital, Bologna, Italy (MF); Department of Medicine, McGill University, Montreal, QC, Canada (MP).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt332DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866157PMC
December 2013

Retromer disruption promotes amyloidogenic APP processing.

Neurobiol Dis 2011 Aug 16;43(2):338-45. Epub 2011 Apr 16.

Geriatric Research, Education, and Clinical Center, Edith Nourse Rogers Memorial Veteran's Administration Hospital, Bedford, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nbd.2011.04.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114192PMC
August 2011

A novel role for calcium/calmodulin kinase II within the brainstem pedunculopontine tegmentum for the regulation of wakefulness and rapid eye movement sleep.

J Neurochem 2010 Jan 26;112(1):271-81. Epub 2009 Oct 26.

Laboratory of Sleep and Cognitive Neurosciences, Boston University School of Medicine, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1471-4159.2009.06452.x
Publisher Site
http://dx.doi.org/10.1111/j.1471-4159.2009.06452.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809126PMC
January 2010

Evidence of oxidant damage in Huntington's disease: translational strategies using antioxidants.

Ann N Y Acad Sci 2008 Dec;1147:79-92

Boston University School of Medicine and the Veterans Administration, Bedford, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1196/annals.1427.008DOI Listing
December 2008

Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice.

Amyotroph Lateral Scler 2009 Apr;10(2):85-94

Department of Neurology, Boston University School of Medicine, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17482960802226148DOI Listing
April 2009

Therapeutic attenuation of mitochondrial dysfunction and oxidative stress in neurotoxin models of Parkinson's disease.

Biochim Biophys Acta 2008 Mar 16;1782(3):151-62. Epub 2008 Jan 16.

Department of Neurology, Boston University School of Medicine, Boston, MA 02118, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbadis.2007.12.006DOI Listing
March 2008

Huntington's disease: progress and potential in the field.

Expert Opin Investig Drugs 2007 Dec;16(12):1933-53

Boston University School of Medicine, Department of Neurology, Boston, Massachusetts, MA 20118, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.16.12.1933DOI Listing
December 2007

Modulation of nucleosome dynamics in Huntington's disease.

Hum Mol Genet 2007 May 2;16(10):1164-75. Epub 2007 Apr 2.

Geriatric Research Education and Clinical Center, Bedford VA Medical Center, Bedford, MA 01730, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/ddm064DOI Listing
May 2007

Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice.

Biochim Biophys Acta 2006 Jun 17;1762(6):616-26. Epub 2006 Apr 17.

Geriatric Research Education and Clinical Center, Bedford VA Medical Center, Bedford 01730, and Neurology Department, Boston University School of Medicine, MA 02180, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbadis.2006.03.004DOI Listing
June 2006

Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice.

Biochim Biophys Acta 2006 Mar 5;1762(3):373-80. Epub 2005 Dec 5.

Geriatric Research Education and Clinical Center, Bedford VA Medical Center, Bedford, MA 01730, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbadis.2005.11.002DOI Listing
March 2006

Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice.

J Comp Neurol 2005 Oct;490(4):354-70

Geriatric Research Education and Clinical Center, Bedford Veterans Administration Medical Center, Bedford, Massachusetts 01730, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cne.20680DOI Listing
October 2005

A functional neuroanatomical investigation of the role of the medial preoptic area in neural circuits regulating maternal behavior.

Behav Brain Res 2002 Apr;131(1-2):17-36

Department of Biology, Boston College, Chestnut Hill, MA 02467, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0166-4328(01)00370-9DOI Listing
April 2002